Monoamine Oxidases in Smoking Pregnant Women and Newborns

计划入组 59 人 · 首次发布于 2005 年 9 月 15 日

Lysyl Oxidase, Semaphorin 7a and Semaphorin 3a in Patients With Systemic Sclerosis

计划入组 30 人 · 首次发布于 2013 年 9 月 17 日

Delivery of Inhibitors of Lysyl Oxidase (LysoLox) on Serial Angioplasty and Time to Restenosis

计划入组 30 人 · 首次发布于 2017 年 4 月 11 日

NADPH oxidases 1 and 4 inhibitors (GenKyoTex)

Iodine I-124 Evuzamitide

PXS-6302

FDA Grants Fast Track Designation to Syntara's SNT-5505 for Myelofibrosis Treatment

iVeena Delivery Systems Announces Successful Phase 1 Results for IVMED-85, a First-in-Class Lysyl Oxidase Activator for Pediatric Myopia

Syntara Initiates First-in-Human Trial of Topical Anti-Fibrotic Drug SNT-9465 for Hypertrophic Scars